BBB BernsteinSep 1, 2026New paperautoPaper35 Targeting HIF2-Driven Endogenous Retroviral Antigens for Immunotherapy in Kidney CancerThe Oncologist · 2026 · Qinqin Jiang, Gürcan Günaydın, Vijyendra Ramesh et al.1